These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 6305166)

  • 1. Effects of kallikrein on human platelet aggregation.
    Ohde H; Mozai T; Hase M; Kitakoji J; Ninomiya F; Chung YH; Fujimoto M
    Adv Exp Med Biol; 1983; 156 (Pt B)():741-5. PubMed ID: 6305166
    [No Abstract]   [Full Text] [Related]  

  • 2. [Inhibitory effect of kallikrein on ristocetin-induced platelet aggregation (author's transl)].
    Fukutake K; Ukita M; Kitamura T; Yamaguchi I
    Nihon Ketsueki Gakkai Zasshi; 1979 Jun; 42(3):549-50. PubMed ID: 495016
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of the 3',5'-cyclic phosphates of 2-methylthioadenosine, 2-chloroadenosine and adenosine on platelet aggregation.
    Maguire MH; Penglis-Caredes F; Gough GR
    Experientia; 1974 Aug; 30(8):922-4. PubMed ID: 4369976
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of adenosine-diphosphate- and collagen-induced platelet aggregation in vitro by UW solution.
    Himmelreich G; Riess H
    Transplant Proc; 1991 Jun; 23(3):1939-40. PubMed ID: 2063433
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of platelet aggregation by moxalactam and free N-methylthiotetrazole.
    Ingalls CS; Somani P; Freimer EH
    Clin Ther; 1989; 11(5):640-51. PubMed ID: 2629724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of platelet activation on the agglutination of platelets by von Willebrand factor.
    Mills DC; Hunchak K; Karl DW; Kirby EP
    Mol Pharmacol; 1990 Feb; 37(2):271-7. PubMed ID: 2154674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo effect of losartan on platelet aggregation in patients with hypertension.
    Akdemir R; Ozhan H; Yazici M; Gunduz H; Duran S; Gurel C; Ozdas S; Uyan C; Basar I; Ulutin T
    Heart Vessels; 2004 Jul; 19(4):167-71. PubMed ID: 15278389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of mycophenolate mofetil and mycophenolic acid on platelet aggregation in vitro.
    Malyszko J; Malyszko JS; Mysliwiec M
    Transplant Proc; 2000 Sep; 32(6):1347-9. PubMed ID: 10995975
    [No Abstract]   [Full Text] [Related]  

  • 9. [Determination of platelet aggregation using the KZM-1-R meter (aggregation inducers: ADP, collagen, ristocetin, ristomycin, adrenaline. Therapy control by use of acetylsalicylic acid)].
    Stepanauskas M; Norden C; Söllner P; Heine H
    Z Med Lab Diagn; 1981; 22(3):148-54. PubMed ID: 6270924
    [No Abstract]   [Full Text] [Related]  

  • 10. ADP, ristocetin, bovine factor VII and thrombasthenic platelets.
    Miragliotta G; Remuzzi G; Minetti B; de Gaetano G
    Thromb Haemost; 1976 Aug; 36(1):286-8. PubMed ID: 1036823
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of heparin on platelet aggregation in vitro].
    Róka L; Isert D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):735-49. PubMed ID: 6083949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Visual micromethod for determining thrombocyte aggregation activity in the presence of different aggregating agents].
    Shitikova AS
    Lab Delo; 1984; (4):215-20. PubMed ID: 6202940
    [No Abstract]   [Full Text] [Related]  

  • 13. Opposite effect of lysine on platelet aggregation induced by arachidonate and by other aggregants.
    Ts'ao C; Hart SJ; Krajewski DV; Sorensen PG
    Thromb Haemost; 1982 Aug; 48(1):78-83. PubMed ID: 6813998
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of endothelin-1 on aggregation of normal and uremic platelets.
    Pawlak K; Małyszko JS; Małyszko J; Myśliwiec M
    Pol J Pharmacol; 1996; 48(2):185-90. PubMed ID: 9112649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of adenosine on levels of adenosine cyclic 3',5'-monophosphate in human blood platelets in relation to adenosine incorporation and platelet aggregation.
    Haslam RJ; Rosson GM
    Mol Pharmacol; 1975 Sep; 11(5):528-44. PubMed ID: 170501
    [No Abstract]   [Full Text] [Related]  

  • 16. Platelet count ratio (PCR) as an additional parameter in the quantitation of platelet aggregation in vitro.
    Benner KU; Tamblyn CH; Swank RL; Seaman GV
    Thromb Res; 1980 Mar; 17(6):801-8. PubMed ID: 7404488
    [No Abstract]   [Full Text] [Related]  

  • 17. Surface-immobilized prostaglandin as a platelet protective agent.
    Grode GA; Pitman J; Crowley JP; Leininger RI; Falb RD
    Trans Am Soc Artif Intern Organs; 1974; 20A():38-41. PubMed ID: 4375330
    [No Abstract]   [Full Text] [Related]  

  • 18. [Assessment of speed of an anti-platelet effect after two different doses of acetylsalicylic acid by flocculation].
    Malý M; Vojácek J; Hadacová I; Mates M; Hájek P; Durdil V
    Vnitr Lek; 2004 Jun; 50(6):428-33. PubMed ID: 15346635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific inhibition of platelet agglutination and aggregation by aromatic amidino compounds.
    Geratz JD; Tidwell RR; Brinkhous KM; Mohammad SF; Dann O; Loewe H
    Thromb Haemost; 1978 Apr; 39(2):411-25. PubMed ID: 580990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of kallikrein on lung metastasis of cancer cells, and its influence on platelet aggregation].
    Kawai Y
    Nihon Gan Chiryo Gakkai Shi; 1985 May; 20(4):765-75. PubMed ID: 3850923
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.